Pyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesis

Dimitrios Anastasiou, Yimin Yu, William J. Israelsen, Jian Kang Jiang, Matthew B. Boxer, Bum Soo Hong, Wolfram Tempel, Svetoslav Dimov, Min Shen, Abhishek Jha, Hua Yang, Katherine R. Mattaini, Christian M. Metallo, Brian P. Fiske, Kevin D. Courtney, Scott Malstrom, Tahsin M. Khan, Charles Kung, Amanda P. Skoumbourdis, Henrike VeithNoel Southall, Martin J. Walsh, Kyle R. Brimacombe, William Leister, Sophia Y. Lunt, Zachary R. Johnson, Katharine E. Yen, Kaiko Kunii, Shawn M. Davidson, Heather R. Christofk, Christopher P. Austin, James Inglese, Marian H. Harris, John M. Asara, Gregory Stephanopoulos, Francesco G. Salituro, Shengfang Jin, Lenny Dang, Douglas S. Auld, Hee Won Park, Lewis C. Cantley, Craig J. Thomas, Matthew G. Vander Heiden

Hematology & Oncology
Internal Medicine

Research output: Contribution to journal › Article › peer-review

564 Scopus citations

Sort by
Weight
Alphabetically

Pyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesis

Fingerprint

Medicine & Life Sciences